Literature DB >> 15243048

Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.

Reidun Øvstebø1, Petter Brandtzaeg, Berit Brusletto, Kari Bente Foss Haug, Knut Lande, Ernst Arne Høiby, Peter Kierulf.   

Abstract

The present study, using robotized DNA isolation and quantitative PCR based on the Neisseria meningitidis-specific capsular transport A gene, demonstrates the ease, rapidity, specificity, and sensitivity of quantifying neisserial DNA in plasma (n = 65) and cerebrospinal fluid (CSF) (n = 12) from patients with systemic meningococcal disease. We found a close correlation between the levels of neisserial DNA and lipopolysaccharides in plasma (r = 0.905) and in CSF (r = 0.964). The median concentration of neisserial DNA in plasma in 23 patients with persistent shock was 2 x 10(7) copies/ml, versus <10(3) copies/ml in 42 nonshock patients. Furthermore, quantitative PCR made possible estimates of the total number of meningococci in plasma, as opposed to conventional blood cultures, suggesting about 1,000 dead meningococci for every viable bacterium. Finally, with logistic regression analyses, neisserial DNA may predict a patient's disease severity and outcome at hospital admission. The number of meningococci in plasma and CSF appears to be the main determinant of the lipopolysaccharide levels, clinical presentation, and outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243048      PMCID: PMC446236          DOI: 10.1128/JCM.42.7.2980-2987.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide.

Authors:  A Bjerre; B Brusletto; E Rosenqvist; E Namork; P Kierulf; R Øvstebø; G B Joø; P Brandtzaeg
Journal:  J Endotoxin Res       Date:  2000

2.  Isolation, culture, and identification of meningococci from clinical specimens.

Authors:  P Olcén; H Fredlund
Journal:  Methods Mol Med       Date:  2001

3.  A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

Authors:  J Meijerink; C Mandigers; L van de Locht; E Tönnissen; F Goodsaid; J Raemaekers
Journal:  J Mol Diagn       Date:  2001-05       Impact factor: 5.568

Review 4.  Host response to Neisseria meningitidis lacking lipopolysaccharides.

Authors:  Petter Brandtzaeg
Journal:  Expert Rev Anti Infect Ther       Date:  2003-12       Impact factor: 5.091

5.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy.

Authors:  P Brandtzaeg; K Bryn; P Kierulf; R Ovstebø; E Namork; B Aase; E Jantzen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

7.  Evaluation of non-culture diagnosis of invasive meningococcal disease by polymerase chain reaction (PCR).

Authors:  Georgina Tzanakaki; Maria Tsolia; Vasiliki Vlachou; Maria Theodoridou; Anastasia Pangalis; Maria Foustoukou; Themistocles Karpathios; C Caroline Blackwell; Jenny Kremastinou
Journal:  FEMS Immunol Med Microbiol       Date:  2003-10-24

8.  An epidemiological, clinical and microbiological follow-up study of incident meningococcal disease cases in Norway, winter 1981-1982. Material and epidemiology in the MenOPP project.

Authors:  T W Gedde-Dahl; E A Høiby; A Schillinger; A Lystad; K Bøvre
Journal:  NIPH Ann       Date:  1983-12

9.  Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease.

Authors:  P Brandtzaeg; P Kierulf; P Gaustad; A Skulberg; J N Bruun; S Halvorsen; E Sørensen
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

10.  Diagnosis of bacteremia in children by quantitative direct plating and a radiometric procedure.

Authors:  L J La Scolea; D Dryja; T D Sullivan; L Mosovich; N Ellerstein; E Neter
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

View more
  40 in total

1.  Meningococcal meningitis.

Authors:  Ricardo G Branco; Robert C Tasker
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

2.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

Review 3.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

4.  High levels of mecA DNA detected by a quantitative real-time PCR assay are associated with mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Ya-Chi Ho; Shan-Chwen Chang; Su-Ru Lin; Wei-Kung Wang
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

5.  Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation.

Authors:  Bernt Christian Hellerud; Jørgen Stenvik; Terje Espevik; John D Lambris; Tom Eirik Mollnes; Petter Brandtzaeg
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

6.  Improved sensitivity for molecular detection of bacterial and Candida infections in blood.

Authors:  Andrea Bacconi; Gregory S Richmond; Michelle A Baroldi; Thomas G Laffler; Lawrence B Blyn; Heather E Carolan; Mark R Frinder; Donna M Toleno; David Metzgar; Jose R Gutierrez; Christian Massire; Megan Rounds; Natalie J Kennel; Richard E Rothman; Stephen Peterson; Karen C Carroll; Teresa Wakefield; David J Ecker; Rangarajan Sampath
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

7.  Early antimicrobial therapy in severe sepsis and septic shock.

Authors:  Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

8.  Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Authors:  Stephen Y Liang; Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

9.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.

Authors:  Bernt Christian Hellerud; Audun Aase; Tove Karin Herstad; Lisbeth Meyer Naess; Lisa Høyem Kristiansen; Anne-Marie Siebke Trøseid; Morten Harboe; Knut Tore Lappegård; Petter Brandtzaeg; E Arne Høiby; Tom Eirik Mollnes
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.